Pfizer

End of Pfizer-Allergan Merger Could Save U.S. Taxpayers Billions

The withdrawal by New York-based pharma giant Pfizer of a proposed merger with Irish company Allergan could save U.S. taxpayers billions. If the merger had been completed under the Treasury Department’s old rules, Pfizer could have dodged paying $35 billion in taxes on $150 billion in overseas profits. In 2014, Treasury revised rules to make …

End of Pfizer-Allergan Merger Could Save U.S. Taxpayers Billions Read More »

Scroll to Top

Madeline Messa

Madeline Messa is a 3L at Syracuse University College of Law. She graduated from Penn State with a degree in journalism. With her legal research and writing for Workplace Fairness, she strives to equip people with the information they need to be their own best advocate.